These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 7534105

  • 21. A developmental context for multiple genetic alterations in Wilms' tumor.
    Feinberg AP.
    J Cell Sci Suppl; 1994; 18():7-12. PubMed ID: 7883796
    [Abstract] [Full Text] [Related]

  • 22. Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells.
    Reeve AE, Sih SA, Raizis AM, Feinberg AP.
    Mol Cell Biol; 1989 Apr; 9(4):1799-803. PubMed ID: 2542777
    [Abstract] [Full Text] [Related]

  • 23. Characterization of regions of chromosomes 12 and 16 involved in nephroblastoma tumorigenesis.
    Austruy E, Candon S, Henry I, Gyapay G, Tournade MF, Mannens M, Callen D, Junien C, Jeanpierre C.
    Genes Chromosomes Cancer; 1995 Dec; 14(4):285-94. PubMed ID: 8605117
    [Abstract] [Full Text] [Related]

  • 24. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.
    Huff V, Reeve AE, Leppert M, Strong LC, Douglass EC, Geiser CF, Li FP, Meadows A, Callen DF, Lenoir G.
    Cancer Res; 1992 Nov 01; 52(21):6117-20. PubMed ID: 1356625
    [Abstract] [Full Text] [Related]

  • 25. Multiple genetic abnormalities of 11p15 in Wilms' tumor.
    Feinberg AP.
    Med Pediatr Oncol; 1996 Nov 01; 27(5):484-9. PubMed ID: 8827078
    [Abstract] [Full Text] [Related]

  • 26. Three non-overlapping regions of chromosome arm 11p allele loss identified in infantile tumors of adrenal and liver.
    Byrne JA, Simms LA, Little MH, Algar EM, Smith PJ.
    Genes Chromosomes Cancer; 1993 Oct 01; 8(2):104-11. PubMed ID: 7504513
    [Abstract] [Full Text] [Related]

  • 27. [Hereditary renal tumors: Wilms' tumor--congenital anomalies' syndrome].
    Tsuchida Y, Yokomori K, Choi SH.
    Nihon Rinsho; 1995 Nov 01; 53(11):2742-8. PubMed ID: 8538037
    [Abstract] [Full Text] [Related]

  • 28. Unbalanced translocation of chromosome 3p in Wilms' tumor.
    Walton JM, Lee CL, Mikhail E, Welch JP, Gillis DA.
    J Pediatr Surg; 1992 Oct 01; 27(10):1311-4. PubMed ID: 1328583
    [Abstract] [Full Text] [Related]

  • 29. Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS).
    Bliek J, Gicquel C, Maas S, Gaston V, Le Bouc Y, Mannens M.
    J Pediatr; 2004 Dec 01; 145(6):796-9. PubMed ID: 15580204
    [Abstract] [Full Text] [Related]

  • 30. Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients.
    Segers H, Kersseboom R, Alders M, Pieters R, Wagner A, van den Heuvel-Eibrink MM.
    Eur J Cancer; 2012 Nov 01; 48(17):3249-56. PubMed ID: 22796116
    [Abstract] [Full Text] [Related]

  • 31. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome.
    Grundy PE, Telzerow PE, Breslow N, Moksness J, Huff V, Paterson MC.
    Cancer Res; 1994 May 01; 54(9):2331-3. PubMed ID: 8162576
    [Abstract] [Full Text] [Related]

  • 32. Allelotyping in Wilms tumors identifies a putative third tumor suppressor gene on chromosome 11.
    Radice P, Perotti D, De Benedetti V, Mondini P, Radice MT, Pilotti S, Luksch R, Fossati Bellani F, Pierotti MA.
    Genomics; 1995 Jun 10; 27(3):497-501. PubMed ID: 7558032
    [Abstract] [Full Text] [Related]

  • 33. The M1 subunit of ribonucleotide reductase refines mapping of genetic rearrangements at chromosome 11p15.
    Byrne JA, Little MH, Smith PJ.
    Cancer Genet Cytogenet; 1992 Apr 10; 59(2):206-9. PubMed ID: 1316226
    [Abstract] [Full Text] [Related]

  • 34. Role of genomic imprinting in Wilms' tumour and overgrowth disorders.
    Reeve AE.
    Med Pediatr Oncol; 1996 Nov 10; 27(5):470-5. PubMed ID: 8827076
    [Abstract] [Full Text] [Related]

  • 35. The chromosome 11 region flanking the t(11;14) breakpoint in human T-ALL is deleted in Wilms' tumor hybrids.
    Finver SN, Martiniere C, Kagan J, Cavenee W, Croce CM.
    Oncogene Res; 1989 Nov 10; 5(2):143-8. PubMed ID: 2558334
    [Abstract] [Full Text] [Related]

  • 36. Fine mapping of Wilms' tumors with 16q loss of heterozygosity localizes the putative tumor suppressor gene to a region of 6.7 megabases.
    Safford SD, Goyeau D, Freemerman AJ, Bentley R, Everett ML, Grundy PE, Skinner MA.
    Ann Surg Oncol; 2003 Mar 10; 10(2):136-43. PubMed ID: 12620908
    [Abstract] [Full Text] [Related]

  • 37. Beck-Wiedemann syndrome and Wilms' tumour.
    Ward A.
    Mol Hum Reprod; 1997 Feb 10; 3(2):157-68. PubMed ID: 9239720
    [Abstract] [Full Text] [Related]

  • 38. Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
    Cowell JK, Groves N, Baird P.
    Br J Cancer; 1993 Jun 10; 67(6):1259-61. PubMed ID: 8390282
    [Abstract] [Full Text] [Related]

  • 39. Paternal origin of 11p15 duplications in the Beckwith-Wiedemann syndrome. A new case and review of the literature.
    Brown KW, Gardner A, Williams JC, Mott MG, McDermott A, Maitland NJ.
    Cancer Genet Cytogenet; 1992 Jan 10; 58(1):66-70. PubMed ID: 1728953
    [Abstract] [Full Text] [Related]

  • 40. Biology of Wilms' tumour.
    Pritchard-Jones K, Hawkins MM.
    Lancet; 1997 Mar 08; 349(9053):663-4. PubMed ID: 9078193
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.